
AksharChem (I) Q3 FY18 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- The company expects an additional revenue of approximately Rs.250 Crores from expansions over the next two years.
- Incremental revenue breakdown:
- - H acid expansion: ~Rs.50 Crores, expected to contribute from FY2019.
- - CPC Green expansion: ~Rs.100 Crores, expected mostly in FY2020.
- - Silica expansion: ~Rs.100 Crores, expected from Q1 FY2020.
- Current planning targets around 80% capacity utilization within two years, with potential to reach 90% later.
- Vinyl Sulphone and CPC Green volumes grew by 10% in nine months FY2018 and 25% in Q3 FY2018 year-on-year.
- New Violet 23 pigment sales are anticipated to start from Q1 FY2019.
- Overall volume growth is forecasted at around 11% aligned with industry expectations.
- The company expects improved revenue and utilization post capacity expansions, gradually increasing revenue growth.
See what AksharChem (I) management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- Currently, the company has zero debt.
- They have raised funds through a Qualified Institutional Placement (QIP).
- They plan to take debt of around Rs. 30-40 Crores towards the closing part of the ongoing capex project.
- The timing of this debt is expected near project completion; no debt is planned immediately.
- They are considering both foreign currency loans and Indian rupee loans depending on the most favorable option at that time.
- Foreign currency loans, if taken, could be offset against exports, reducing currency risk.
- No immediate equity fundraising mentioned beyond the QIP already completed.
See what AksharChem (I) management said on order book — free account, 30 seconds.
Capex plans
Yes- Ongoing expansions include CPC Green (480 tonnes per annum), Silica, and H Acid projects.
- Expected incremental revenues from expansions: Rs.50 Crores from H Acid, Rs.100 Crores from Green expansion, Rs.100 Crores from Silica.
- H Acid expansion revenue to start contributing from Q1 FY2019.
- Silica expansion revenue expected from Q1 FY2020.
- CPC Green second phase expansion to complete in next 12 months.
- Violet 23 pigment plant commenced trial production; expected sales from Q1 FY2019.
- CPC Blue project is underway for captive consumption but will not contribute to revenues.
- Total new capex incremental revenue expected around Rs.250 Crores, with Rs.50 Crores in FY2019 and Rs.200 Crores in FY2020.
- Debt planned to support capex around Rs.30-40 Crores, undecided on foreign currency or rupee loans.
- Capex expected to complete within next 12 months.
Track AksharChem (I) — get its next earnings analysis in your feed
How does AksharChem (I) rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does AksharChem (I) rank in Chemicals & Petrochemicals?
Compare AksharChem (I) against every Chemicals & Petrochemicals company (Q3 FY18) on revenue, margins and earnings-call signals.
Continue your research
What AksharChem (I)'s management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- GOCL Corporation Ltd (Q2 FY27)
Year-on-year (YoY) increase in revenue from operations: Approximately 85% increase (41,063 vs. Key results statement takeaways from GOCL Corpn.'s Q2 FY27 result
- Bhansali Engineering Polymers Ltd (Q2 FY27)
Revenue from operations (net) for the quarter ended 30/09/2026 is ₹40,336.95 lakhs, compared to ₹32,509.76 lakhs for the quarter ended 30/09/2025, reflecting a…
- Tatva Chintan (Q2 FY27)
Q2 FY27 revenue from operations: ₹2,173 Mn, up 76% YoY from ₹1,235 Mn in Q2 FY26 (Page 11). Key investor presentation takeaways from Tatva Chintan's Q2 FY27 inv
- Devson Catalyst Ltd (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee